25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

4BB (4basebio) Stock Analysis
Buy, Hold or Sell?

Let's analyze 4basebio together

I guess you are interested in 4BASEBIO UK SOCIETAS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – 4basebio’s Financial Insights
  • 📈 Technical Analysis (TA) – 4basebio’s Price Targets

I'm going to help you getting a better view of 4BASEBIO UK SOCIETAS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about 4BASEBIO UK SOCIETAS

I send you an email if I find something interesting about 4BASEBIO UK SOCIETAS.

1. Quick Overview

1.1. Quick analysis of 4basebio (30 sec.)










1.2. What can you expect buying and holding a share of 4basebio? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p170.50
Expected worth in 1 year
p865.23
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
p694.73
Return On Investment
70.5%

For what price can you sell your share?

Current Price per Share
p985.00
Expected price per share
p901.00 - p1,070
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of 4basebio (5 min.)




Live pricePrice per Share (EOD)
p985.00
Intrinsic Value Per Share
p-1,064.32 - p-1,047.58
Total Value Per Share
p-893.82 - p-877.08

2.2. Growth of 4basebio (5 min.)




Is 4basebio growing?

Current yearPrevious yearGrowGrow %
How rich?$36.2m-$676.4k$36.9m101.9%

How much money is 4basebio making?

Current yearPrevious yearGrowGrow %
Making money-$16.9m-$10.5m-$6.4m-37.8%
Net Profit Margin-1,321.9%-1,514.8%--

How much money comes from the company's main activities?

2.3. Financial Health of 4basebio (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of 4basebio?

Welcome investor! 4basebio's management wants to use your money to grow the business. In return you get a share of 4basebio.

First you should know what it really means to hold a share of 4basebio. And how you can make/lose money.

Speculation

The Price per Share of 4basebio is p985.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 4basebio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 4basebio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p170.50. Based on the TTM, the Book Value Change Per Share is p173.68 per quarter. Based on the YOY, the Book Value Change Per Share is p-49.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 4basebio.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-1.10-0.1%-1.10-0.1%-0.68-0.1%-0.74-0.1%-0.52-0.1%-0.460.0%
Usd Book Value Change Per Share2.390.2%2.390.2%-0.68-0.1%0.430.0%0.500.1%0.390.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.390.2%2.390.2%-0.68-0.1%0.430.0%0.500.1%0.390.0%
Usd Price Per Share16.64-16.64-9.35-11.91-8.84-7.37-
Price to Earnings Ratio-15.18--15.18--13.73--16.75--15.93--13.27-
Price-to-Total Gains Ratio6.97-6.97--13.82--10.29--14.04--14.04-
Price to Book Ratio7.10-7.10--213.84--63.77--36.64--30.53-
Price-to-Total Gains Ratio6.97-6.97--13.82--10.29--14.04--14.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.54178
Number of shares73
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share2.390.50
Usd Total Gains Per Share2.390.50
Gains per Quarter (73 shares)174.3136.68
Gains per Year (73 shares)697.23146.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106976870147137
20139413840293284
30209220810440431
40278927780587578
50348634750734725
60418341720880872
7048814869010271019
8055785566011741166
9062756263013201313
10069726960014671460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%2.04.00.033.3%2.04.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%2.04.00.033.3%2.04.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of 4BASEBIO UK SOCIETAS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--173.683173.6830%-49.199+128%31.638+449%36.544+375%28.417+511%
Book Value Per Share--170.503170.5030%-3.180+102%71.114+140%77.768+119%62.771+172%
Current Ratio--11.29811.2980%2.206+412%5.796+95%8.691+30%7.419+52%
Debt To Asset Ratio--0.4100.4100%1.041-61%0.614-33%0.436-6%0.803-49%
Debt To Equity Ratio--0.6950.6950%-+100%0.446+56%0.349+99%0.291+139%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--16886299000.00016886299000.0000%9586392000.000+76%12478646666.667+35%11902264625.000+42%11902264625.000+42%
Eps---79.712-79.7120%-49.541-38%-54.180-32%-37.619-53%-33.172-58%
Ev To Sales Ratio--180.989180.9890%189.454-4%259.840-30%270.125-33%270.125-33%
Free Cash Flow Per Share---79.596-79.5960%-49.561-38%-57.369-28%-42.336-47%-35.789-55%
Free Cash Flow To Equity Per Share---79.596-79.5960%-8.034-90%-40.846-49%-14.377-82%-11.965-85%
Gross Profit Margin--1.0001.0000%1.037-4%1.028-3%1.064-6%1.061-6%
Intrinsic Value_10Y_max---1047.578----------
Intrinsic Value_10Y_min---1064.322----------
Intrinsic Value_1Y_max---55.966----------
Intrinsic Value_1Y_min---70.509----------
Intrinsic Value_3Y_max---205.506----------
Intrinsic Value_3Y_min---244.411----------
Intrinsic Value_5Y_max---400.077----------
Intrinsic Value_5Y_min---452.664----------
Market Cap15239821500.000-23%18720999000.00018720999000.0000%10520892000.000+78%13408980000.000+40%9948431700.000+88%8290359750.000+126%
Net Profit Margin---13.219-13.2190%-15.148+15%-15.861+20%-11.742-11%-10.134-23%
Operating Margin----0%-15.9130%-12.5680%-9.8970%-8.5940%
Operating Ratio--15.03615.0360%16.913-11%18.247-18%13.704+10%11.933+26%
Pb Ratio5.777-23%7.0977.0970%-213.839+3113%-63.771+999%-36.636+616%-30.530+530%
Pe Ratio-12.357+19%-15.180-15.1800%-13.726-10%-16.745+10%-15.930+5%-13.275-13%
Price Per Share985.000-23%1210.0001210.0000%680.000+78%866.667+40%643.000+88%535.833+126%
Price To Free Cash Flow Ratio-12.375+19%-15.202-15.2020%-13.721-10%-15.1510%-13.566-11%-11.305-26%
Price To Total Gains Ratio5.671-23%6.9676.9670%-13.821+298%-10.289+248%-14.038+302%-14.038+302%
Quick Ratio--0.0870.0870%1.498-94%1.548-94%6.051-99%5.146-98%
Return On Assets---0.276-0.2760%-0.643+133%-0.453+64%-0.324+17%-0.331+20%
Return On Equity---0.468-0.4680%--100%-0.397-15%-0.303-35%-0.252-46%
Total Gains Per Share--173.683173.6830%-49.199+128%31.638+449%36.544+375%28.417+511%
Usd Book Value--36267224.00036267224.0000%-676401.600+102%15126466.133+140%16541868.560+119%13351828.467+172%
Usd Book Value Change Per Share--2.3882.3880%-0.676+128%0.435+449%0.502+375%0.391+511%
Usd Book Value Per Share--2.3442.3440%-0.044+102%0.978+140%1.069+119%0.863+172%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--232152838.652232152838.6520%131793717.216+76%171556434.373+35%163632334.065+42%163632334.065+42%
Usd Eps---1.096-1.0960%-0.681-38%-0.745-32%-0.517-53%-0.456-58%
Usd Free Cash Flow---16930662.000-16930662.0000%-10541966.400-38%-12202724.800-28%-9005214.960-47%-7612496.733-55%
Usd Free Cash Flow Per Share---1.094-1.0940%-0.681-38%-0.789-28%-0.582-47%-0.492-55%
Usd Free Cash Flow To Equity Per Share---1.094-1.0940%-0.110-90%-0.562-49%-0.198-82%-0.164-85%
Usd Market Cap209517065.982-23%257376294.252257376294.2520%144641223.216+78%184346657.040+40%136771039.012+88%113975865.843+126%
Usd Price Per Share13.542-23%16.63516.6350%9.349+78%11.915+40%8.840+88%7.367+126%
Usd Profit---16955408.400-16955408.4000%-10537842.000-38%-11524490.133-32%-8001885.920-53%-6765161.667-60%
Usd Revenue--1282688.4001282688.4000%695648.800+84%782261.200+64%689324.720+86%620722.200+107%
Usd Total Gains Per Share--2.3882.3880%-0.676+128%0.435+449%0.502+375%0.391+511%
 EOD+2 -6MRQTTM+0 -0YOY+21 -153Y+20 -165Y+18 -1810Y+19 -17

3.3 Fundamental Score

Let's check the fundamental score of 4BASEBIO UK SOCIETAS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.357
Price to Book Ratio (EOD)Between0-15.777
Net Profit Margin (MRQ)Greater than0-13.219
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.087
Current Ratio (MRQ)Greater than111.298
Debt to Asset Ratio (MRQ)Less than10.410
Debt to Equity Ratio (MRQ)Less than10.695
Return on Equity (MRQ)Greater than0.15-0.468
Return on Assets (MRQ)Greater than0.05-0.276
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of 4BASEBIO UK SOCIETAS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than503.393
Ma 20Greater thanMa 501,020.750
Ma 50Greater thanMa 1001,081.500
Ma 100Greater thanMa 2001,107.400
OpenGreater thanClose985.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About 4BASEBIO UK SOCIETAS

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5' and 3' ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

Fundamental data was last updated by Penke on 2025-06-25 19:03:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit 4basebio earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • A Net Profit Margin of -1,321.9% means that -13.22 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is -1,321.9%. The company is making a huge loss. -2
  • The TTM is -1,321.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,321.9%TTM-1,321.9%0.0%
TTM-1,321.9%YOY-1,514.8%+193.0%
TTM-1,321.9%5Y-1,174.2%-147.7%
5Y-1,174.2%10Y-1,013.4%-160.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,321.9%-90.3%-1,231.6%
TTM-1,321.9%-141.5%-1,180.4%
YOY-1,514.8%-185.9%-1,328.9%
3Y-1,586.1%-248.0%-1,338.1%
5Y-1,174.2%-344.1%-830.1%
10Y-1,013.4%-489.2%-524.2%
4.3.1.2. Return on Assets

Shows how efficient 4basebio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • -27.6% Return on Assets means that 4basebio generated -0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is -27.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.6%TTM-27.6%0.0%
TTM-27.6%YOY-64.3%+36.7%
TTM-27.6%5Y-32.4%+4.8%
5Y-32.4%10Y-33.1%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.6%-11.5%-16.1%
TTM-27.6%-11.6%-16.0%
YOY-64.3%-11.4%-52.9%
3Y-45.3%-11.9%-33.4%
5Y-32.4%-12.2%-20.2%
10Y-33.1%-13.9%-19.2%
4.3.1.3. Return on Equity

Shows how efficient 4basebio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • -46.8% Return on Equity means 4basebio generated -0.47 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is -46.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -46.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.8%TTM-46.8%0.0%
TTM-46.8%YOY--46.8%
TTM-46.8%5Y-30.3%-16.5%
5Y-30.3%10Y-25.2%-5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.8%-13.5%-33.3%
TTM-46.8%-15.0%-31.8%
YOY--14.4%+14.4%
3Y-39.7%-17.0%-22.7%
5Y-30.3%-18.0%-12.3%
10Y-25.2%-20.4%-4.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of 4BASEBIO UK SOCIETAS.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient 4basebio is operating .

  • Measures how much profit 4basebio makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,591.3%+1,591.3%
TTM-5Y-989.7%+989.7%
5Y-989.7%10Y-859.4%-130.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.5%+229.5%
TTM--258.2%+258.2%
YOY-1,591.3%-204.2%-1,387.1%
3Y-1,256.8%-221.0%-1,035.8%
5Y-989.7%-344.1%-645.6%
10Y-859.4%-476.7%-382.7%
4.3.2.2. Operating Ratio

Measures how efficient 4basebio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 15.04 means that the operating costs are 15.04 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 15.036. The company is inefficient in keeping operating costs low. -1
  • The TTM is 15.036. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ15.036TTM15.0360.000
TTM15.036YOY16.913-1.877
TTM15.0365Y13.704+1.332
5Y13.70410Y11.933+1.771
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.0362.110+12.926
TTM15.0362.711+12.325
YOY16.9133.043+13.870
3Y18.2473.562+14.685
5Y13.7044.755+8.949
10Y11.9336.520+5.413
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of 4BASEBIO UK SOCIETAS.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if 4basebio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.30 means the company has 11.30 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 11.298. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.298. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.298TTM11.2980.000
TTM11.298YOY2.206+9.092
TTM11.2985Y8.691+2.607
5Y8.69110Y7.419+1.272
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.2983.662+7.636
TTM11.2983.745+7.553
YOY2.2064.104-1.898
3Y5.7964.649+1.147
5Y8.6915.734+2.957
10Y7.4196.143+1.276
4.4.3.2. Quick Ratio

Measures if 4basebio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • A Quick Ratio of 0.09 means the company can pay off 0.09 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.087. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.087. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.0870.000
TTM0.087YOY1.498-1.412
TTM0.0875Y6.051-5.964
5Y6.05110Y5.146+0.905
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0872.826-2.739
TTM0.0873.104-3.017
YOY1.4983.778-2.280
3Y1.5484.288-2.740
5Y6.0515.682+0.369
10Y5.1466.360-1.214
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of 4BASEBIO UK SOCIETAS.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of 4basebio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare 4basebio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that 4basebio assets are financed with 41.0% credit (debt) and the remaining percentage (100% - 41.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.410. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.410. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.410TTM0.4100.000
TTM0.410YOY1.041-0.631
TTM0.4105Y0.436-0.026
5Y0.43610Y0.803-0.367
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4100.324+0.086
TTM0.4100.349+0.061
YOY1.0410.329+0.712
3Y0.6140.339+0.275
5Y0.4360.349+0.087
10Y0.8030.384+0.419
4.5.4.2. Debt to Equity Ratio

Measures if 4basebio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 69.5% means that company has 0.70 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.695. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.695. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.695TTM0.6950.000
TTM0.695YOY-+0.695
TTM0.6955Y0.349+0.346
5Y0.34910Y0.291+0.058
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6950.384+0.311
TTM0.6950.435+0.260
YOY-0.408-0.408
3Y0.4460.4460.000
5Y0.3490.460-0.111
10Y0.2910.510-0.219
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings 4basebio generates.

  • Above 15 is considered overpriced but always compare 4basebio to the Biotechnology industry mean.
  • A PE ratio of -15.18 means the investor is paying -15.18 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 4BASEBIO UK SOCIETAS:

  • The EOD is -12.357. Based on the earnings, the company is expensive. -2
  • The MRQ is -15.180. Based on the earnings, the company is expensive. -2
  • The TTM is -15.180. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.357MRQ-15.180+2.823
MRQ-15.180TTM-15.1800.000
TTM-15.180YOY-13.726-1.454
TTM-15.1805Y-15.930+0.750
5Y-15.93010Y-13.275-2.655
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.357-2.150-10.207
MRQ-15.180-2.004-13.176
TTM-15.180-2.524-12.656
YOY-13.726-3.716-10.010
3Y-16.745-3.703-13.042
5Y-15.930-6.057-9.873
10Y-13.275-6.653-6.622
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 4BASEBIO UK SOCIETAS:

  • The EOD is -12.375. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.202. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.202. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.375MRQ-15.202+2.827
MRQ-15.202TTM-15.2020.000
TTM-15.202YOY-13.721-1.481
TTM-15.2025Y-13.566-1.635
5Y-13.56610Y-11.305-2.261
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.375-3.030-9.345
MRQ-15.202-2.710-12.492
TTM-15.202-3.643-11.559
YOY-13.721-4.385-9.336
3Y-15.151-5.050-10.101
5Y-13.566-8.550-5.016
10Y-11.305-9.339-1.966
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of 4basebio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.10 means the investor is paying 7.10 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of 4BASEBIO UK SOCIETAS:

  • The EOD is 5.777. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.097. Based on the equity, the company is overpriced. -1
  • The TTM is 7.097. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.777MRQ7.097-1.320
MRQ7.097TTM7.0970.000
TTM7.097YOY-213.839+220.936
TTM7.0975Y-36.636+43.732
5Y-36.63610Y-30.530-6.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.7771.883+3.894
MRQ7.0971.855+5.242
TTM7.0972.119+4.978
YOY-213.8392.469-216.308
3Y-63.7712.504-66.275
5Y-36.6363.657-40.293
10Y-30.5304.297-34.827
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets44,727
Total Liabilities18,347
Total Stockholder Equity26,380
 As reported
Total Liabilities 18,347
Total Stockholder Equity+ 26,380
Total Assets = 44,727

Assets

Total Assets44,727
Total Current Assets36,888
Long-term Assets7,839
Total Current Assets
Cash And Cash Equivalents 34,604
Net Receivables 283
Inventory 374
Other Current Assets 336
Total Current Assets  (as reported)36,888
Total Current Assets  (calculated)35,597
+/- 1,291
Long-term Assets
Property Plant Equipment 4,326
Intangible Assets 3,480
Long-term Assets  (as reported)7,839
Long-term Assets  (calculated)7,806
+/- 33

Liabilities & Shareholders' Equity

Total Current Liabilities3,265
Long-term Liabilities15,082
Total Stockholder Equity26,380
Total Current Liabilities
Short Long Term Debt 147
Accounts payable 1,694
Other Current Liabilities 62
Total Current Liabilities  (as reported)3,265
Total Current Liabilities  (calculated)1,903
+/- 1,362
Long-term Liabilities
Long term Debt 14,294
Capital Lease Obligations Min Short Term Debt775
Long-term Liabilities  (as reported)15,082
Long-term Liabilities  (calculated)15,069
+/- 13
Total Stockholder Equity
Total Stockholder Equity (as reported)26,380
Total Stockholder Equity (calculated)0
+/- 26,380
Other
Capital Stock13,772
Common Stock Shares Outstanding 15,472
Net Invested Capital 40,821
Net Working Capital 33,623
Property Plant and Equipment Gross 6,486



6.2. Balance Sheets Structured

Currency in GBP. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
1,155
17,809
14,702
11,689
11,922
44,727
44,72711,92211,68914,70217,8091,155
   > Total Current Assets 
598
15,512
10,642
5,897
5,022
36,888
36,8885,0225,89710,64215,512598
       Cash And Cash Equivalents 
80
15,001
9,586
4,351
3,069
34,604
34,6043,0694,3519,58615,00180
       Short-term Investments 
196
219
228
240
236
0
0236240228219196
       Net Receivables 
77
39
604
54
107
283
283107546043977
       Other Current Assets 
339
341
296
1,359
1,514
336
3361,5141,359296341339
   > Long-term Assets 
557
2,297
4,060
5,792
6,900
7,839
7,8396,9005,7924,0602,297557
       Property Plant Equipment 
77
1,478
2,759
3,633
4,197
4,326
4,3264,1973,6332,7591,47877
       Intangible Assets 
450
785
1,271
2,124
2,669
3,480
3,4802,6692,1241,271785450
       Long-term Assets Other 
30
34
30
35
34
0
03435303430
> Total Liabilities 
3,045
2,351
3,007
4,569
12,414
18,347
18,34712,4144,5693,0072,3513,045
   > Total Current Liabilities 
566
813
1,523
1,518
2,277
3,265
3,2652,2771,5181,523813566
       Short-term Debt 
446
416
432
415
392
0
0392415432416446
       Short Long Term Debt 
397
349
356
321
263
147
147263321356349397
       Accounts payable 
101
96
353
490
694
1,694
1,69469449035396101
       Other Current Liabilities 
19
301
738
613
1,191
62
621,19161373830119
   > Long-term Liabilities 
2,479
1,538
1,484
3,051
10,137
15,082
15,08210,1373,0511,4841,5382,479
       Long term Debt 
2,142
1,229
860
2,414
9,304
14,294
14,2949,3042,4148601,2292,142
       Capital Lease Obligations Min Short Term Debt
-397
-277
110
200
498
775
775498200110-277-397
       Other Liabilities 
337
237
158
0
0
0
000158237337
       Long-term Liabilities Other 
0
237
158
116
0
0
001161582370
       Deferred Long Term Liability 
382
683
1,104
0
0
0
0001,104683382
> Total Stockholder Equity
-1,890
15,458
11,695
7,120
-492
26,380
26,380-4927,12011,69515,458-1,890
   Common Stock
6,362
11,130
11,130
11,130
11,132
0
011,13211,13011,13011,1306,362
   Retained Earnings -38,723-26,390-18,725-13,575-10,340-9,621
   Accumulated Other Comprehensive Income 
1,369
13,274
12,746
13,321
13,372
0
013,37213,32112,74613,2741,369
   Capital Surplus 000000
   Treasury Stock000000



6.3. Balance Sheets

Currency in GBP. All numbers in thousands.




6.4. Cash Flows

Currency in GBP. All numbers in thousands.




6.5. Income Statements

Currency in GBP. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in GBP. All numbers in thousands.

Gross Profit (+$)
totalRevenue933
Cost of Revenue-303
Gross Profit630630
 
Operating Income (+$)
Gross Profit630
Operating Expense-13,726
Operating Income-12,793-13,096
 
Operating Expense (+$)
Research Development4,684
Selling General Administrative1,765
Selling And Marketing Expenses0
Operating Expense13,7266,449
 
Net Interest Income (+$)
Interest Income140
Interest Expense-752
Other Finance Cost-0
Net Interest Income-612
 
Pretax Income (+$)
Operating Income-12,793
Net Interest Income-612
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,654-12,793
EBIT - interestExpense = -752
-12,333
-11,581
Interest Expense752
Earnings Before Interest and Taxes (EBIT)0-11,902
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-12,654
Tax Provision--321
Net Income From Continuing Ops-12,333-12,333
Net Income-12,333
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0612
 

Technical Analysis of 4basebio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 4basebio. The general trend of 4basebio is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 4basebio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. 4basebio Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 4BASEBIO UK SOCIETAS.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1,020 < 1,070 < 1,070.

The bearish price targets are: 950.00 > 940.00 > 901.00.

Know someone who trades $4BB? Share this with them.👇

4BASEBIO UK SOCIETAS Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 4BASEBIO UK SOCIETAS. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

4BASEBIO UK SOCIETAS Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 4BASEBIO UK SOCIETAS. The current macd is -32.27480901.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the 4basebio price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for 4basebio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the 4basebio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
4BASEBIO UK SOCIETAS Daily Moving Average Convergence/Divergence (MACD) Chart4BASEBIO UK SOCIETAS Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 4BASEBIO UK SOCIETAS. The current adx is 39.77.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell 4basebio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
4BASEBIO UK SOCIETAS Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 4BASEBIO UK SOCIETAS. The current sar is 1,010.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
4BASEBIO UK SOCIETAS Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 4BASEBIO UK SOCIETAS. The current rsi is 3.39276792. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
4BASEBIO UK SOCIETAS Daily Relative Strength Index (RSI) Chart4BASEBIO UK SOCIETAS Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 4BASEBIO UK SOCIETAS. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 4basebio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
4BASEBIO UK SOCIETAS Daily Stochastic Oscillator Chart4BASEBIO UK SOCIETAS Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 4BASEBIO UK SOCIETAS. The current cci is -71.52768011.

4BASEBIO UK SOCIETAS Daily Commodity Channel Index (CCI) Chart4BASEBIO UK SOCIETAS Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 4BASEBIO UK SOCIETAS. The current cmo is -99.03221556.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
4BASEBIO UK SOCIETAS Daily Chande Momentum Oscillator (CMO) Chart4BASEBIO UK SOCIETAS Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 4BASEBIO UK SOCIETAS. The current willr is -67.85714286.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that 4basebio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
4BASEBIO UK SOCIETAS Daily Williams %R Chart4BASEBIO UK SOCIETAS Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of 4BASEBIO UK SOCIETAS.

4BASEBIO UK SOCIETAS Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 4BASEBIO UK SOCIETAS. The current atr is 33.45.

4BASEBIO UK SOCIETAS Daily Average True Range (ATR) Chart4BASEBIO UK SOCIETAS Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 4BASEBIO UK SOCIETAS. The current obv is 734,356.

4BASEBIO UK SOCIETAS Daily On-Balance Volume (OBV) Chart4BASEBIO UK SOCIETAS Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 4BASEBIO UK SOCIETAS. The current mfi is 36.23.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
4BASEBIO UK SOCIETAS Daily Money Flow Index (MFI) Chart4BASEBIO UK SOCIETAS Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 4BASEBIO UK SOCIETAS.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

4BASEBIO UK SOCIETAS Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 4BASEBIO UK SOCIETAS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than503.393
Ma 20Greater thanMa 501,020.750
Ma 50Greater thanMa 1001,081.500
Ma 100Greater thanMa 2001,107.400
OpenGreater thanClose985.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of 4basebio with someone you think should read this too:
  • Are you bullish or bearish on 4basebio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 4basebio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 4BASEBIO UK SOCIETAS

I send you an email if I find something interesting about 4BASEBIO UK SOCIETAS.


Comments

How you think about this?

Leave a comment

Stay informed about 4BASEBIO UK SOCIETAS.

Receive notifications about 4BASEBIO UK SOCIETAS in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.